Published in Oncotarget on July 10, 2017
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
Calcium-channel blockade and incidence of cancer in aged populations. Lancet (1996) 8.04
Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med (2013) 4.36
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J Hypertens (2011) 3.26
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol (2010) 2.77
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Hypertension, diuretics and breast cancer risk. J Hum Hypertens (2006) 1.90
Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension. Am J Cardiol (2011) 1.86
Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther (2002) 1.82
Calcium channel blockers and the risk of cancer. JAMA (1998) 1.78
Insulin resistance and breast-cancer risk. Int J Cancer (1992) 1.57
A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat (2006) 1.57
Reserpine use in relation to breast cancer. Lancet (1974) 1.51
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer (1997) 1.50
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med (2000) 1.44
Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer (2000) 1.36
Use of angiotensin receptor blockers and the risk of cancer. Circulation (2011) 1.25
A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer (2005) 1.23
Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer (2001) 1.21
Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control (2010) 1.16
Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. Cancer Lett (2012) 1.06
Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer (2008) 1.02
Medication use and the risk of breast cancer. Eur J Epidemiol (2007) 0.98
Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS One (2012) 0.97
Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study. Br J Clin Pharmacol (2012) 0.97
Long-term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiol Drug Saf (2008) 0.95
Use of antihypertensive medications and breast cancer risk. Cancer Causes Control (2012) 0.94
Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf (2004) 0.92
The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion. Endocr Relat Cancer (2006) 0.90
Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One (2012) 0.89
Antihypertensive medication use and incident breast cancer in women. Breast Cancer Res Treat (2015) 0.89
Long-term use of angiotensin II receptor blockers and risk of cancer: a population-based cohort analysis. Int J Cardiol (2012) 0.88
Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol (2012) 0.87
Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer (2004) 0.87
Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ (2012) 0.86
Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Res (2016) 0.85
Spironolactone use and the risk of breast and gynecologic cancers. Cancer Epidemiol (2013) 0.83
Hypertension and breast cancer: an association revisited? J Hum Hypertens (2006) 0.82
Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies. Pharmacoepidemiol Drug Saf (2014) 0.82
Diuretic use and the risk of breast cancer. J Hum Hypertens (2008) 0.81
Calcium channel blockers and risk of breast cancer: a meta-analysis of 17 observational studies. PLoS One (2014) 0.81
Carcinogenicity of antihypertensive therapy. Curr Hypertens Rep (2002) 0.80
Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol Rep (2012) 0.79
Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells. Thromb Res (2011) 0.79
Breast carcinoma and antihypertensive therapy. Cancer (2003) 0.79
Long-Term Use of Antihypertensive Agents and Risk of Breast Cancer: A Population-Based Case-Control Study. Cardiol Ther (2015) 0.79
Propranolol Reduces Cancer Risk: A Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.79
Antihypertensive agents, insulin sensitivity, and new-onset diabetes. Curr Diab Rep (2007) 0.79
The association between antihypertensive drugs and glioma. Br J Cancer (2006) 0.77
Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study. J Hypertens (2016) 0.76
Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study. Epidemiology (2016) 0.76
Can antihypertensive drugs increase the risk of cancer? Trends Mol Med (2011) 0.76
Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer. Int J Cancer (2016) 0.75
Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies. PLoS One (2015) 0.83
Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies. Oncotarget (2017) 0.75